show episodes
 
Artwork

1
Actions on Diabetes

Diabetes Action Canada

Unsubscribe
Unsubscribe
Monthly
 
When patients are involved in research, extraordinary things can be achieved. Actions on Diabetes shares the stories of Diabetes Action Canada researchers and Patient Partners as they work together to transform the lives of all Canadians with diabetes.
  continue reading
 
No nagging and no lecturing! Just good information about what's new for people with type 2 diabetes. A lot has changed; there are new tools and even new ways of thinking about diabetes. We're sharing quick facts and bringing you interviews with tech companies, advocates, and fascinating people living with type 2. Host Stacey Simms has been called “A diabetes podcast pioneer” by Healthline. You’ll get actionable info that will help you thrive!
  continue reading
 
Loading …
show series
 
DIY Pioneer Dana Lewis was diagnosed with something called EPI – exocrine pancreatic insufficiency a couple of years ago. She’d never heard of it and was shocked to find out diabetes is considered a common co-condition. In fact, 20-30 percent of people with diabetes can end up with EPI. EPI can cause a lot of discomfort and stomach issues – and hea…
  continue reading
 
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The Eversense CGM could soon be approved for one year of continuous use, the first generic GLP-1 medication is launched, a new company tauts and all-in-one sensor and pump infusion set, a new diabetes accessory in the Roblox game, and more! Find…
  continue reading
 
Medications like Ozempic and Mounjaro have fundamentally changed the way diabetes is treated. But even if your doctor writes the prescription and your insurance company covers it, getting your hands on the medication is getting harder and harder. We’re talking about what to do if you’re having trouble here – tips if you have to start and stop – and…
  continue reading
 
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens - and why this could happen anywhere, once-weekly insulin is approved in Canada, update on Omnipod 5 with Dexcom G7 rollout, more older people are getting type 1 but more people are living longer with it, CG…
  continue reading
 
Have you heard of a diabetologist? This is a newer specialty in the U-S that may help offset the lack of endocrinologists. Most people with type 2 see a general practitioner and the diabetology certification helps those doctors learn about the latest in diabetes care. We’ll talk about how to find one of these rare experts, why there could be more o…
  continue reading
 
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about metformin during pregnancy, an update on semaglutides, JDRF changes its name, and more! We have a monthly newsletter! Sign up today (no spam we promise)…
  continue reading
 
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by computer scientist Len Testa and endocrinologist Dr. Bradly Eilerman. Len Testa is also co host of the fabulous Disney Dish podcast and the creator of…
  continue reading
 
This week, talking with one of the lawyers bringing a class-action lawsuit against the insulin companies.. a lawsuit that has been inching forward since 2017. It was set to be settled for 500-million dollars and a four year price cap, but then judge said no. Attorney Steve Berman will talk about that last minute surprise, why he's still going forwa…
  continue reading
 
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: more older adults are being diagnosed with type 1 and people with T1D are living longer, Eversense gets iCGM designation, new drug to prevent low BG is being tested, Tandem diabetes app recall, and more! Find out more about Moms' Night Out Pleas…
  continue reading
 
We're taking a close up look at hospital care when you have type 2 – from the people who grade the hospitals. 30% of patients admitted for acute care have diabetes. But many hospitals aren’t prepared or have staff trained to take care of this. My guests – from the watchdog group Leapfrog and from the ADA, will talk about what’s been doing right and…
  continue reading
 
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study links emulsifiers, a common ingrediant, to type 2 diabetes, reserachers map out the pancreas in a new way that's already yielding new information, new guidliens about using GLP-1s and SGLT-2 medications with exisiting oral meds, gene…
  continue reading
 
We’re talking to a sports illustrated swimsuit model – who lives with type 2! Nina Cash is also in her late 50s – so being a swimsuit model wasn’t something she really thought was in the cards – she spent her career in education and retired as a University Dean. She’ll tell us the story of how the SI gig happened and why she’s park of the rookie cl…
  continue reading
 
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT di…
  continue reading
 
Diabetes education is boring. Right? Yeah educators think so too. So what can we do to make it better? We’re talking about a new effort to talk to people with diabetes and find out what works for you. I’m talking to Dr Bill Polonksy from the Behavioral Diabetes Institute This podcast is not intended as medical advice. If you have those kinds of que…
  continue reading
 
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and…
  continue reading
 
This endocrinologist tries to have every single one of his patients use a CGM – that’s people with type 1 and type 2. Dr. Thomas Grace is going to explain the specific benefits he thinks people who don’t use insulin can get from a CGM, and shares a few studes just released at big diabetes conference, including those around using GLP-1s.. medication…
  continue reading
 
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The annual ATTD conference wraps up with news about CGMs, including new FDA approvals and a look at CGMs outside of the US, new eyedrops are being studied to treat diabetic eye disease and Beyond Type 1 opens applications for their annual Beyond…
  continue reading
 
It's pretty clear that the future of medicine will include artificial intelligence. It’s already part of doctor’s appointments, health data, and more. But balancing that machine learning high tech with a doctor’s personal touch is going to be tricky. This week, we’re talking about the art of medicine with endocrinologist and author Dr. Allen Sussma…
  continue reading
 
What you need to know about diabetes and your eyes. I know, this one can make people nervous, but the most important thing to know is that treatments have changed A LOT and they are much more effective than you might think. We’ll also define the most common type of diabetic eye complication, retinopathy. Our conversation this week is a little diffe…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: what is MicroGlucagon and how could it speed up existing rapid-acting insulin? SGLT2 medications may cause false positive alcohol tests, red light therapy for type 2 diabetes, research shows teens with type 2 might have a diff…
  continue reading
 
What you eat is an important part of managing diabetes. By now, we all know being super restrictive doesn’t work, so let’s talk about some easier ways to work in more healthy foods without turning your life upside down. My guest this week is Dr. Mike Roussell, an author and nutrition consultant who holds a degree in biochemistry and a PHD in nutrit…
  continue reading
 
Clinical trials are the way we test new drugs or therapies on people, and they’re incredibly important to moving diabetes research forward. However, they can be challenging and complicated to develop and fund. That’s where the new Diabetes Clinical Trials Network in Canada comes in. This episode's guests are Dr. Hertzel Gerstein, who is leading thi…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Tandem announces it's taking orders and starting to ship the Mobi pump, Insulet gets European approval for the Abbott Libre integration with Omnipod 5, new study looks at type 2 remission and gastric bypass surgery, one type o…
  continue reading
 
Dexcom is planning a new CGM system called Stelo, aimed at people with type 2 diabetes who don't use insulin. This week, we're talking to the Chief Operating Officer Jake Leach all about this. Dexcom is the leading CGM used with insulin pumps, so this is an interesting new direction for them. What’s the difference between this device and those made…
  continue reading
 
Getting a CGM is, more and more, becoming a routine part of a diabetes diagnosis. But figuring out if your insurance will pay can be anything but routine. A new pilot program is recruiting pharmacists to be a big part of this process, helping educate patients about their options, even writing prescriptions. Plus, with all the talk about CGM, you ma…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a look at how weight loss might lower cancer risk in people with type 2, a new study that says BG spikes are good(?!), Modular Medical submits a new insulin pump the FDA, another look at COVID-19's effects on people with diabe…
  continue reading
 
My guest is Matt Friedman, an expert in public relations who lives with type 2 – we get his take on what’s going on in PR these days – with social media, crisis control, and even CHatGPT and AI – and of course we’ll talk about diabetes, and the bone Matt has to pick with restaurants. I love talking abou technology and the majority of these episodes…
  continue reading
 
Let’s talk about using insulin. For some, that can feel like a huge failure or that they have the bad type of diabetes. But sometimes, diet and exercise isn’t enough to manage type 2 diabetes. My guest this week is Dr. Arthi Thangudu and she’s going to talk about how she approaches these conversations with her patients and some of the newer options…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Vertex pauses their stem cell transplantation trials after a patient death, spray insulin is tested, learning more about Dexcom's sensor for type 2, measuring A1C through menstrual blood and more! Find out more about Moms' Nig…
  continue reading
 
When you get a diabetes diagnosis, eating well is usually at the top of the “to-do” list. But then you get home and look around the kitchen and – let’s face it – most of us aren’t sure where to start. What’s easy to cook that will taste good? What will my family actually eat? This week I’m talking to Chef Robert Lewis, who calls himself the happy d…
  continue reading
 
Diabetes is a 24-hour condition with no vacations or days off. Those who live with it understand that diabetes distress – the term for mental health challenges specific to diabetes – is very real and can be very challenging to manage. It can also have a big impact on other aspects of diabetes care – like this A1Cs doctors are always checking. This …
  continue reading
 
This time of year diets are the center of a lot of conversations. So when I heard WeightWatchers was specifically offering something for people with diabetes, I wanted to learn more. WeightWatchers is teaming up with Abbott to use the Freestyle Libe CGM as part of their newest program. What does really mean for people with type 2? What are they off…
  continue reading
 
Today on Diabetes Connections Type 2: Let’s talk about diabetes distress and how to manage it. Not sure what that even means? My guest is Dr. Bill Polonksy – a diabetes psychologist – who has an incredible message around mental health and diabetes. He’ll explain how addressing the real-life emotional aspects of diabetes is critical for long-term he…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at food-as-medicine for type 2, another FDA warning about fake Ozempic, new research says gut markers may help predict who Tzield will work best for, JDRF partners with NFL and more... Happy New Year - we'll …
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: an existing drug for arthritis is being studied for treatment of T1D, poison control centers report a big increase in calls about misdosing of Ozmepic and semaglutides, Tandem releases it's Tandem Source software, we've got an…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: infusion set recall, update on ViaCyte stem cell research, a few new studies look at sleep and diabetes, actual clinical research into cinnamon for type 1 and lots more. Links & transcript below Find out more about Moms' Night…
  continue reading
 
GEM is being called a radical new way to treat diabetes and The National Institutes of Health is giving millions to study it. We’re going to talk about Glucose Everyday Matters (also called Glucose Excursion Minimization) with Dr. Daniel Cox, the UVA researcher who lives with type 2 and developed it. Let’s also talk about insulin resistance. You’ve…
  continue reading
 
This week's guest had such a strong family history of diabetes that she decided gastric bypass surgery was the right option for her. That was more than ten years ago – how is Ramona Holloway – and her diabetes - doing now? Plus, you’ve probably heard of a CGM. How does it work? Is there more than one kind? This podcast is not intended as medical ad…
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Novo Nordisk will discontinue Levemir by the end of 2024, Tandem begins limited launch of software updates that will include Dexcom's G7, Beta Bionics iLet pump will be covered until some pharmacy plans, and lots more! Links a…
  continue reading
 
Do you know your rights with diabetes? Our guest this week is John Griffin, a trial lawyer with more than 30 years of advocating in and out of the courtroom. He lives with type 2 himself – this is an eye opening and useful conversation. Griffin served as National Chair of the Board of the American Diabetes Association in 2011, and is the former Cha…
  continue reading
 
Often newcomers don’t know about access to eye screening, or there are cultural or other barriers that aren’t being addressed. But early detection of diabetic retinopathy can save sight and have a huge impact on the overall health of a person. Today’s guests want to make sure those barriers are overcome. Host Krista Lamb talks to Dr. Joyce Dogba fr…
  continue reading
 
Professional golfer Ken Duke plays on the PGA Champions Tour; you may have seen him win this summer. You may not know he lives with type 2. He shares how he was diagnosed, how he manages on the tour, and I ask for some advice for my golf game. Plus, Metformin is probably the most prescribed diabetes drug. What is it? How does it work? This podcast …
  continue reading
 
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at pancreatic exocrine-endocrine “crosstalk,” weekly basal for T1D moves forward, a Chinese company gets European approval for its CGM, a look at air pollution as a cause of T2D, lots of info and advocacy for…
  continue reading
 
Medications like Ozempic, Wegovy and Mounjaro are getting a lot of attention. What are they? How do they work to help people with diabetes and should you think about taking one? Plus we’ll break down the difference between type 1 and type 2. I get this question a lot – so let’s explain it. This podcast is not intended as medical advice. If you have…
  continue reading
 
On this episode of Actions on Diabetes, host Krista Lamb will be chatting with two guests who are looking at ways to improve the coordination of care for people living with type 1 diabetes. The Reshape T1D project tries to understand how people interact with the health care system by involving those living with T1D and their clinicians in designing…
  continue reading
 
Think Patient Partners can't participate in discovery-level research? Think again! Host Krista Lamb talks with Dr. Rob Screaton from the University of Toronto, Patient Partner Zoe Hilton and trainee scientist Cassie Locatelli. These three guests are working on a project incorporating Patient Partners into an islet biology training program.…
  continue reading
 
While people living with diabetes are at increased risk for diabetic retinopathy, they often face barriers to getting their eyes checked—or simply don’t know they need to go every year. In this episode, Malcolm Sissmore and Dr. Michael Brent from UHN Research discuss their work on Project OPEN, a research program that’s trying to make eye screening…
  continue reading
 
Loading …

Quick Reference Guide